Dr. Schwartzman and Dr. Ruderman discuss the importance of a domain-based approach in PsA management and consider the potential role of a JAK inhibitor. Sponsored by AbbVie Medical Affairs + Health Impact.
https://buff.ly/9gUnxB7
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.